Covance is the only CRO partner that can deliver solutions from discovery to commercialization.
Are your economic models delivering?
Transform economic models into highly engaging communication tools.
Rare Disease and Orphan Drugs
Webinar: accelerate complex studies across the globe
A range of individual approaches can be integrated to accelerate your progress of complex rare disease studies across the world. Learn how to address key development challenges.
Solutions to minimize risk and optimize your trial designs
Discover how our innovation, commitment and expertise can accelerate your complex immuno-oncology drug development
Early Phase Development Solutions
Want to reduce your early development timeline by 30%?
Find out how from Pete Sausen, PhD, vice president, early phase development solutions
Optimize your biomarker approach with an experienced partner
Covance / LabCorp has supported more than 75 percent of all FDA-approved companion/complementary diagnostic assays.
Elevate your protocol execution and compliance with actionable insights from Covance and Global Specimen Solutions
Introducing SpecimINSIGHT™: Break down data silos using GlobalCODE® to aggregate specimen data from multiple sources. Enhance trial design with retrospective data analytics. Quickly respond to additional "in-life" testing requests with comprehensive consent visibility. Minimize the risk of regulatory delays.
TQT waivers: one year later
Learn about TQT waiver limitations, common strategy and design questions
The diabetic heart: A focus on heart failure
February 15, 2017 | 11 a.m. EST
Join us to hear an insightful discussion on how certain molecular classes impact CV outcomes for patients with Type 2 diabetes along with strategies for testing new therapeutic, paradigm-modifying treatment modalities.
We’ve helped the pharmaceutical industry develop more medicines than any other company.
Inclusion/exclusion criteria: a case study
Improving recruitment through the application of proprietary LabCorp data
New FDA labeling regulations are here
The new label is intended to better inform consumers about their choices.
We’re the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges.